11-101-8646
Mercaptopurine Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Manufacturer: MilliporeSigma Supelco
CAS Number: 6112-76-1
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 11-101-8646-Each-of-1 | In Stock | ₹ 37,825.00 |
11-101-8646 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 37,825.00
GST (18%): ₹ 6,808.50
Total Price: ₹ 44,633.50
CAS
6112-76-1
Type
Certified Reference Material
Linear Formula
C5H4N4 S·H2O
Synonym
6-Mercaptopurine monohydrate; 6-Purinethiol; 6-Thiohypoxanthine
Grade
Certified Reference Material
Quantity
1 g
Purity Grade Notes
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
MDL Number
MFCD03854445
Formula Weight
170.19
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Chem-Impex International, Inc. 6-Mercaptopurine monohydrate | 6112-76-1 | MFCD01461928 | 100G | -- | ₹ 26,034.28 | ||
Sigma Aldrich Fine Chemicals Biosciences 6-Mercaptopurine monohydrate 98% | 6112-76-1 | MFCD03854445 | 5G | -- | ₹ 10,564.30 | ||
eMolecules Ambeed / 7H-Purine-6-thiol hydrate / 10g / 552631182 / A189537 / / 6112-76-1 / [null] / 170.190 / C5H6N4OS | -- | ₹ 2,969.04 | ||
Sigma Aldrich Fine Chemicals Biosciences Mercaptopurine United States Pharmacopeia (USP) Reference Standard | 6112-76-1 | MFCD03854445 | 500MG | -- | ₹ 47,632.80 | ||
Mercaptopurine | -- | ₹ 21,789.30 | ||
Mercaptopurine | -- | ₹ 41,791.50 | ||
Mercaptopurine impurity standard | -- | ₹ 21,323.10 | ||
Mercaptopurine | -- | ₹ 25,840.80 | ||
6-Mercaptopurine hydrate | -- | ₹ 2,136.00 - ₹ 9,434.00 | ||
6112-76-1 | 6-Mercaptopurine monohydrate | -- | ₹ 890.00 - ₹ 34,087.00 |
Related Products
Description
- Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
- Mercaptopurine is an anticancer and an immunosuppressive drug employed for the management of acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), Crohn′s disease, etc
- Its mode of action involves interference in the nucleic acid synthesis by the inhibition of purine metabolism.